The latest closing stock price for TScan Therapeutics as of November 22, 2024 is 4.26.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-594 today, roughly -1 times their original investment - a -25.97% compound annual growth rate over 3 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 127.5% above the current share price.
The TScan Therapeutics 52-week low stock price is 3.92, which is 8% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 6.39.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-594 today, roughly -1 times their original investment - a -25.97% compound annual growth rate over 3 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 127.5% above the current share price.
The TScan Therapeutics 52-week low stock price is 3.92, which is 8% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 6.39.